Despite wealth of attention, new female libido pill isn’t selling
The number of prescriptions for Addyi, the women’s libido-boosting pill, in its first few weeks? 227.
Health Care
Articles
Heft not enough to justify insurer deals, top DOJ lawyer says
Assistant Attorney General William Baer said that consumer choice is a bigger priority than health companies’ desire to add market share and gain leverage over providers like hospitals.
FBI probe puts private Jackson family in spotlight
The family's American Senior Communities is the dominant nursing home company in Indiana, with 94 long-term care facilities.
SMARTT: Health disparities among Amos’ many causes
Before his untimely death, Amos Brown used his media pulpit to raise awareness among minority populations about their elevated risks of heart disease, diabetes and stroke.
Doctor group asks regulators to block health insurer mergers
Anthem Inc. shouldn’t be permitted to buy Cigna Corp. and Aetna Inc. should be blocked from acquiring Humana Inc., the American Medical Association said in a letter Wednesday to the head of the Justice Department’s antitrust division.
Lilly, other drugmakers face federal pricing probe
Indianapolis-based Eli Lilly and Co. and other U.S. drugmakers are being investigated by federal prosecutors over their drug-pricing practices related to Medicare and Medicaid, according to newspaper reports.
New state program aims more money at treating offenders
Starting Nov. 1, courts, probation and parole officers and community correction managers were able to begin referring eligible felons to designated drug and mental health treatment centers instead of to jail or prison.
Advantage Health to exit Medicare business after $46M in losses
Advantage Health Solutions was placed under the supervision of the Indiana Department of Insurance on Friday after the company lost $46.3 million during the first eight months of the year and decided to terminate its Medicare Advantage business.
UPDATE: Eli Lilly to build $70M R&D building in Indianapolis
The 130,000-square-foot building will be designed to encourage collaboration among scientists across different disciplines, which the company said is crucial to fostering innovation.
Caregivers see need for more pint-sized medical devices
Companies—including Indiana-based OrthoPediatrics Corp.—are starting to answer parents’ call for more help for children.
Approach may boost success of stem cell transplants
Researchers at the Indiana University School of Medicine found that blocking the activity of a key protein can significantly cut down on the graft-versus-host immune response suffered by large numbers of patients who receive stem cell transplants.
Elanco president makes case for juiced-up cows in organic age
Jeff Simmons is on a counteroffensive as, increasingly, the drugs that Elanco makes—including antibiotics and productivity enhancers—have come under attack by food activists.
Sandra Eskenazi donates $5M toward brain initiative
Sandra is the daughter of Sidney and Lois Eskenazi, the couple who provided a $40 million gift to the Eskenazi Health Capital Campaign and for whom the Eskenazi Health system is named.
Governor weighs in on criticism of HPV vaccine letter
The Indiana State Department of Health sent letters to 305,000 parents who haven’t vaccinated their children for a virus known to cause cervical cancer. Conservative groups have objected to what they call an intrusion into parenting decisions.
Papa John’s CEO gives $1M to St. V to house patient families
The Indianapolis-based hospital system announced the donation from John Schnatter Thursday during a groundbreaking ceremony for St. Vincent House, which will include private units for 20 families who have a child or loved receiving extended care.
Pharmaceutical firms losing business to darknet drug deals
For the $300 billion pharmaceutical industry, the rapid growth of illegal underground marketplaces is a serious threat to profits and reputations.
Health law penalty on uninsured getting stiffer
The federal penalty for having no health insurance is set to jump to $695, and the Obama administration is being urged to highlight that cold fact to help drive more sign-ups.
Lilly competitor fails to win FDA backing for diabetes treatment
AstraZeneca Plc didn’t receive U.S. approval for a new diabetes treatment that combines two of its existing drugs. The combination would have competed with Glyxambi from Lilly.
Pence awards $3.5M contract to anti-abortion charity group
Gov. Mike Pence cited the successes of a $1 million pilot program as reason for granting a new $3.5 million contract to Real Alternatives, a Pennsylvania-based charity.
Indiana Blood Center names new chief executive
Long-time health care executive Charles C. Miraglia was picked by the center’s board of directors to replace interim CEO Dan A. Waxman, who has been in that position since January.